Device Trial Radar · NCT06110117
Assess Efficacy and Safety of a Nasal Spray in Adults With Dry or Irritated Nose
Last checked: Nov 20, 2026Latest source record: Nov 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
Oct 27, 2023
Primary completion
Mar 15, 2024
Study completion Nov 4, 2024
Sponsor
- Lead sponsor
- Church & Dwight Company, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 31, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to test symptom relief in subjects suffering from irritated or dry nasal passages. The main question it aims to answer is whether use of the nasal spray provides relief from dry nose symptoms. Participants will use the product for one week and report on the severity of their symptoms before and during use.
Conditions
- Dry Nose
Interventions
Sterimar Stop & Protect Irritation & DrynessDevice
One or two nasal sprays will be administered to each nostril for a minimum of 2 times per day up to a maximum of 6 times per day for seven days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in patient-reported total irritation score from baselineTime frame: One week of product use.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Eurofins Dermscan Poland
Gdansk, Poland
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.